1 Min Read
Aug 21 (Reuters) - EQL PHARMA AB
* CONSOLIDATED SALES FOR Q2 AMOUNTED TO SEK 6.7 (4.6) MILLION
* EBITDA FOR Q2 AMOUNTED TO SEK 0.1 (0.5) MILLION Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.